These Healthcare stocks are trading higher:
-Regulus Therapeutics Inc (RGLS) stock is trading at $2.63, a rise of $1.25, or 70.94%, on high volume. Regulus Therapeutics gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $10.50. Regulus Therapeutics next reports earnings on March 28.
-Lantern Pharma Inc (LTRN) stock is trading at $7.45, an increase of $1.13, or 17.89%, on moderate volume. Lantern Pharma Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $26.00. Lantern Pharma Inc next reports earnings on March 18.
-Viracta Therapeutics Inc (VIRX) stock is trading at $1.02, a rise of $0.13, or 15.85%, on high volume. Viracta Therapeutics Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $7.00.
-Greenwich Lifesciences Inc (GLSI) stock is trading at $20.29, an increase of $2.61, or 15.3%, on high volume. Greenwich Lifesciences Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $36.00. Greenwich Lifesciences Inc next reports earnings on March 29.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Lexaria Bioscience Corp (LEXX) stock is trading at $4.07, a loss of $2.18, or 31.36%, on high volume. Lexaria Bioscience Corp gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $6.50.
-Caribou Biosciences Inc (CRBU) stock is trading at $5.45, a drop of $1.77, or 24.1%, on high volume. Caribou Biosciences Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $22.00. Caribou Biosciences Inc next reports earnings on March 14.
-Aslan Pharmaceuticals Ltd (ASLN) stock is trading at $1.28, a loss of $0.35, or 21.47%, on high volume. Aslan Pharmaceuticals Ltd ADR gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $16.00. Aslan Pharmaceuticals Ltd ADR next reports earnings on March 22.
-Virpax Pharmaceuticals Inc (VRPX) stock is trading at $3.94, a decline of $1.01, or 19.6%, on high volume. Virpax Pharmaceuticals Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $20.00. Virpax Pharmaceuticals Inc next reports earnings on March 27.
Find the top stocks in the Healthcare Sector here.